Pd-l1 expression among different subtypes of chinese breast cancer patients

被引：0

作者：

Liao, Ning ^{[1
]}

Li, Cao ^{[1
]}

Wu, Jundong ^{[2
]}

Chen, Bo ^{[1
]}

Zhang, Guochun ^{[1
]}

Li, Xueri ^{[1
]}

Guo, Liping ^{[1
]}

Wei, Guangnan ^{[1
]}

Lin, Jiali ^{[1
]}

Li, Yingzi ^{[1
]}

Zhang, Yuchen ^{[1
]}

Mok, Hsiaopei ^{[1
]}

Ren, Chongyang ^{[1
]}

Wang, Yulei ^{[1
]}

Li, Kai ^{[1
]}

Li, Cheukfai ^{[1
]}

Wen, Lingzhu ^{[1
]}

Jia, Minghan ^{[1
]}

Lin, Tengjiao ^{[3
]}

Cheng, Chunyan ^{[3
]}

机构：

[1] Guangdong Prov Peoples Hosp & Guangdong Acad Med, Dept Breast Canc, Guangzhou, Peoples R China

[2] Shantou Univ, Coll Med, Canc Hosp, Guangdong Prov Key Lab Breast Canc Diag & Treatme, Shantou, Peoples R China

[3] OrigiMed, Shanghai, Peoples R China

来源：

CANCER RESEARCH | 2021年 / 81卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PS17-44

引用

页数：1

共 50 条

[21] PD-L1 Protein Expression in Algerian Inflammatory Breast Cancer (IBC) Patients
Arias-Pulido, Hugo
Cimino-Mathews, Ashley
Chaher, Nabila
Joste, Nancy
Qualls, Clifford
Foisey, Max
Marotti, Jonathan
Emens, Leisha
Fiering, Steven
LABORATORY INVESTIGATION, 2018, 98 : 45 - 45
[22] PD-L1 Protein Expression in Algerian Inflammatory Breast Cancer (IBC) Patients
Arias-Pulido, Hugo
Cimino-Mathews, Ashley
Chaher, Nabila
Joste, Nancy
Qualls, Clifford
Foisey, Max
Marotti, Jonathan
Emens, Leisha
Fiering, Steven
MODERN PATHOLOGY, 2018, 31 : 45 - 45
[23] PD-1, PD-L1, and B7-H3 Expression in Intrinsic Molecular Subtypes of Breast Cancer
Rose, Gary
Richards, Stephanie
Rosenblatt, Paula
Koka, Madhurima
Tuttle, Kimberly
Cellini, Ashley
Ioffe, Olga
MODERN PATHOLOGY, 2017, 30 : 68A - 68A
[24] PD-1, PD-L1, and B7-H3 Expression in Intrinsic Molecular Subtypes of Breast Cancer
Rose, Gary
Richards, Stephanie
Rosenblatt, Paula
Kaka, Madhurima
Tuttle, Kimberly
Cellini, Ashley
Ioffe, Olga
LABORATORY INVESTIGATION, 2017, 97 : 68A - 68A
[25] Immunomodulatory effects of entinostat on PD-L1 and MHC class I and II in different subtypes of breast cancer
Chumsri, S.
Necela, B. M.
Ordentlich, P.
Advani, P.
Moreno-Aspitia, A.
McLaughlin, S. A.
Geiger, X.
McDonough, M.
Vallow, L. A.
Perez, E. A.
Thompson, E. A.
CANCER RESEARCH, 2016, 76
[26] PD-L1 expression in breast carcinoma
Papaioannou, E.
Kourea, E.
Beslika, E.
Tzelepi, V.
Sakellakis, M.
Kyriakopoulos, D.
Melachrinou, M.
VIRCHOWS ARCHIV, 2016, 469 : S22 - S22
[27] PD-L1 in Breast Cancer: 3 Different Scoring Systems
Boles, Dina
Slodkowska, Elzbieta
Jerzak, Katarzyna J.
Warner, Ellen
Zhu, Siqi
Pond, Gregory
Nofech-Mozes, Sharon
MODERN PATHOLOGY, 2019, 32
[28] PD-L1 in Breast Cancer: 3 Different Scoring Systems
Boles, Dina
Slodkowska, Elzbieta
Jerzak, Katarzyna J.
Warner, Ellen
Zhu, Siqi
Pond, Gregory
Nofech-Mozes, Sharon
LABORATORY INVESTIGATION, 2019, 99
[29] PD-L1 Over-Expression Varies in Different Subtypes of Lung Cancer: Will This Affect Future Therapies?
Ullah, Asad
Pulliam, Steven
Karki, Nabin Raj
Khan, Jaffar
Jogezai, Sana
Sultan, Sandresh
Muhammad, Lal
Khan, Marjan
Jamil, Nimra
Waheed, Abdul
Belakhlef, Sami
Ghleilib, Intisar
Vail, Eric
Heneidi, Saleh
Karim, Nagla Abdel
CLINICS AND PRACTICE, 2022, 12 (05) : 653 - 671
[30] Frequent expression of PD-L1 on circulating breast cancer cells
Mazel, Martine
Jacot, William
Pantel, Klaus
Bartkowiak, Kai
Topart, Delphine
Cayrefourcq, Laure
Rossille, Delphine
Maudelonde, Thierry
Fest, Thierry
Alix-Panabieres, Catherine
MOLECULAR ONCOLOGY, 2015, 9 (09): : 1773 - 1782

← 1 2 3 4 5 →